FRTX_logo_color 2.jpg
Fresh Tracks Therapeutics Urges Stockholders to Vote at the Upcoming Special Meeting on February 15th
February 14, 2024 12:47 ET | Fresh Tracks Therapeutics, Inc.
Stockholders of record on January 11, 2024 who have not yet voted are encouraged to do so by 11:59 p.m. Eastern Time on February 14, 2024 BOULDER, Colo., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Fresh...
FRTX_logo_color 2.jpg
Fresh Tracks Therapeutics Announces Plan to Hold New Special Meeting of Stockholders on February 15th
December 27, 2023 16:05 ET | Fresh Tracks Therapeutics, Inc.
New record date expected to be January 11, 2024 Company intends to seek judicial dissolution if the liquidation and dissolution is not approved by Fresh Tracks’ stockholders at new special meeting,...
FRTX_logo_color 2.jpg
Fresh Tracks Therapeutics Announces Listing on OTC Pink Market
December 19, 2023 17:18 ET | Fresh Tracks Therapeutics, Inc.
BOULDER, Colo., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Fresh Tracks Therapeutics, Inc. (OTC Pink: FRTX) (“Fresh Tracks” or the “Company”) announced today that the Company’s common stock was suspended...
FRTX_logo_color 2.jpg
Fresh Tracks Therapeutics Announces its Common Stock will be Suspended from Trading on Nasdaq at Open of Business on December 19th
December 18, 2023 08:15 ET | Fresh Tracks Therapeutics, Inc.
BOULDER, Colo., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Fresh Tracks Therapeutics, Inc. (Nasdaq: FRTX) (“Fresh Tracks” or the “Company”) announced today receipt of a notice from Nasdaq stating that the...
FRTX_logo_color 2.jpg
Fresh Tracks Therapeutics Announces Third Adjournment of Special Meeting of Stockholders
December 15, 2023 16:05 ET | Fresh Tracks Therapeutics, Inc.
Meeting adjourned to December 27, 2023 at 10 a.m. MT Fresh Tracks encourages all stockholders of record on October 17, 2023 who have not yet voted to do so by 11:59 p.m. Eastern Time on December 26,...
FRTX_logo_color 2.jpg
Fresh Tracks Therapeutics Announces Second Adjournment of Special Meeting of Stockholders
December 01, 2023 17:00 ET | Fresh Tracks Therapeutics, Inc.
Meeting adjourned to December 15, 2023 at 10 a.m. MT Fresh Tracks encourages all stockholders of record on October 17, 2023 who have not yet voted to do so by 11:59 p.m. Eastern Time on December 14,...
FRTX_logo_color 2.jpg
Fresh Tracks Therapeutics Announces Adjournment of Special Meeting of Stockholders
November 17, 2023 08:30 ET | Fresh Tracks Therapeutics, Inc.
Meeting adjourned to November 30, 2023 at 10 a.m. MT Fresh Tracks encourages all stockholders of record on October 17, 2023 who have not yet voted to do so by 11:59 p.m. Eastern Time on...
FRTX_logo_color 2.jpg
Fresh Tracks Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 13, 2023 08:30 ET | Fresh Tracks Therapeutics, Inc.
Cash and cash equivalents of approximately $11.5 million as of October 31, 2023 Special meeting of stockholders on November 16 seeking stockholder approval of the Dissolution and Plan of Dissolution ...
FRTX_logo_color 2.jpg
Fresh Tracks Therapeutics Announces Board Approval of Plan of Liquidation and Dissolution
September 19, 2023 16:01 ET | Fresh Tracks Therapeutics, Inc.
BOULDER, Colo., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Fresh Tracks Therapeutics, Inc. (the “Company” or “Fresh Tracks”) (Nasdaq: FRTX) today announced that, after conducting an extensive potential...
FRTX_logo_color 2.jpg
Fresh Tracks Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 11, 2023 16:01 ET | Fresh Tracks Therapeutics, Inc.
Strengthened current cash position to approximately $15 million as of July 31, 2023 as a result of sale of future rights to event-based milestone and earnout payments on net sales of sofpironium...